Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1

被引:117
作者
Hargitai, J
Lewis, H
Boros, I
Rácz, T
Fiser, A
Kurucz, I
Benjamin, I
Vígh, L
Pénzes, Z
Csermely, P
Latchman, DS
机构
[1] Biorex R&D Co, H-8201 Veszprem, Hungary
[2] Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England
[3] Hungarian Acad Sci, Biol Res Ctr, Dept Biochem, H-6701 Szeged, Hungary
[4] Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA
[5] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA
[6] Semmelweis Univ, Dept Med Chem, H-1444 Budapest 8, Hungary
关键词
chaperones; Hsp47; Hsp70; Hsp90; HSF-1; bimoclomol;
D O I
10.1016/S0006-291X(03)01254-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The novel hydroxylamine derivative, bimoclomol, has been shown previously to act as a co-inducer of several heat shock proteins (Hsp-s), enhancing the amount of these proteins produced following a heat shock compared to heat shock alone. Here we show that the co-inducing effect of bimoclomol on Hsp expression is mediated via the prolonged activation of the heat shock transcription factor (HSF-1). Bimoclomol effects are abolished in cells from mice lacking HSF-1. Moreover, bimoclomol binds to HSF-1 and induces a prolonged binding of HSF-1 to the respective DNA elements. Since HSF-1 does not bind to DNA in the absence of stress, the bimoclomol-induced extension of HSF-1/DNA interaction may contribute to the chaperone co-induction of bimoclomol observed previously. These findings indicate that bimoclomol may be of value in targeting HSF-1 so as to induce up-regulation of protective Hsp-s in a non-stressful manner and for therapeutic benefit. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:689 / 695
页数:7
相关论文
共 24 条
[1]  
AUSUBEL FM, 2001, CURRENT PROTOCOLS MO
[2]   Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats [J].
Bíró, K ;
Pálhalmi, J ;
Tóth, AJ ;
Kukorelli, T ;
Juhász, G .
NEUROREPORT, 1998, 9 (09) :2029-2033
[3]   Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats [J].
Biro, K ;
Jednakovits, A ;
Kukorelli, T ;
Hegedus, E ;
Koranyi, L .
BRAIN RESEARCH BULLETIN, 1997, 44 (03) :259-263
[4]  
CSERMELY P, 1993, J BIOL CHEM, V268, P1901
[5]   Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats [J].
Erdö, F ;
Erdö, SL .
BRAIN RESEARCH BULLETIN, 1998, 45 (02) :163-166
[6]   DIFFERENTIAL DISTRIBUTION OF 70-KD HEAT-SHOCK PROTEIN IN ATHEROSCLEROSIS - ITS POTENTIAL ROLE IN ARTERIAL SMC SURVIVAL [J].
JOHNSON, AD ;
BERBERIAN, PA ;
TYTELL, M ;
BOND, MG .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (01) :27-36
[7]   AFFINITY PURIFICATION OF SEQUENCE-SPECIFIC DNA-BINDING PROTEINS [J].
KADONAGA, JT ;
TJIAN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :5889-5893
[8]  
Kurucz I, 1999, CELL STRESS CHAPERON, V4, P139
[9]   Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats [J].
Lubbers, NL ;
Polakowski, JS ;
Wegner, CD ;
Burke, SE ;
Diaz, GJ ;
Daniell, KM ;
Cox, BF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 435 (01) :79-83
[10]   Determination of the consensus binding sequence for the purified embryonic heat shock factor 2 [J].
Manuel, M ;
Rallu, M ;
Loones, MT ;
Zimarino, V ;
Mezger, V ;
Morange, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (10) :2527-2537